NASDAQ: LTRN
Lantern Pharma Inc Stock Ownership - Who owns Lantern Pharma?

Insider buying vs selling

Have Lantern Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
D. Jeffrey KeyserDirector2026-05-1248,544$2.06
$100.00kBuy
Lee Troy SchalopDirector2026-05-1248,544$2.06
$100.00kBuy

1 of 1

LTRN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LTRN insiders and whales buy or sell their stock.

LTRN Shareholders

What type of owners hold Lantern Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Leslie W. Kreis18.63%2,958,970$973.50kInsider
Aaron Gl Fletcher6.77%1,075,952$353.99kInsider
Biological Mimetics Inc6.57%1,044,000$343.48kInsider
David S. Silberstein6.57%1,044,000$343.48kInsider
Arunkumar Asaithambi2.78%441,960$145.40kInsider
Green Park Golf Ventures II LLC0.83%131,697$43.33kInsider
D. Jeffrey Keyser0.59%94,303$31.03kInsider
Lee Troy Schalop0.31%48,544$15.97kInsider
Armistice Capital LLC0.01%1,036$340.84Institution
Empery Asset Management LP0.00%543$178.65Institution

1 of 3

LTRN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LTRN0.02%43.05%Net Buying
CRIS0.00%100.00%Net Buying
OPHI0.01%93.98%
JAGX0.00%74.98%
PCSA0.11%99.89%Net Buying

Lantern Pharma Stock Ownership FAQ

Who owns Lantern Pharma?

Lantern Pharma (NASDAQ: LTRN) is owned by 0.02% institutional shareholders, 43.05% Lantern Pharma insiders, and 56.92% retail investors. Leslie W. Kreis is the largest individual Lantern Pharma shareholder, owning 2.96M shares representing 18.63% of the company. Leslie W. Kreis's Lantern Pharma shares are currently valued at $840.35k.

If you're new to stock investing, here's how to buy Lantern Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.